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Fungal infections are associated with morbidity and mortality especially in in patients with underlying medical 
conditions. With the increasing number of immune-compromised patients, the burden of invasive fungal infections 
became widespread. 
In any country, data on fungal infection is important to design appropriate programs as well as to plan and implement 
further studies. A review of literature on fungal infections in Ethiopia shows that there is paucity of evidences on 
this problem and existing ones focused mainly on superficial and mucosal fungal infections while there is almost 
none on an invasive or systemic infection [Ethiop. J. Health Dev.  2017;31(2):124-126]. 
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Introduction 
Fungi are eukaryotic organisms that cause a range of 
clinical infections including skin, hair, nail, mucosal, 
subcutaneous, and invasive infections. Majority of fungi 
cause opportunistic infections in patients with other 
underlying immune-suppression such as HIV infection, 
chemotherapy induced neutropenia in cancer patients, 
solid organ transplant patients receiving 
immunosuppressive therapy, and patients with chronic 
obstructive lung disease (1). Fungi also play a role in 
allergic fungal disease such as allergic broncho-
pulmonary Aspergilosis (ABPA) and chronic or deep 
tissue infections. The laboratory diagnosis of fungal 
infection starts with a simple potassium hydroxide 
(KOH) wet mount for superficial infections to more 
difficult and complex methods for systemic infection 
including clinical vigilance for signs, imaging 
procedures, culture, serology, molecular techniques (2). 
The number of patients with the risk of invasive fungal 
infections is increasing in Ethiopia. This brief 
communication intends to shade light on the gaps of 
research based evidence in the area of serious and life 
threatening fungal infections in Ethiopia. 
 
Methods 
Review of existing literature on fungal infections in 
Ethiopia was done using the following  key terms: 
“fungal infection and Ethiopia”, “candidiasis and 
Ethiopia”, “candidaemia and Ethiopia “,  “invasive 
fungal infections and Ethiopia”, “Aspergillosis and 
Ethiopia”, “dermatophytosis and Ethiopia”, 
“Cryptococcus and Ethiopia”, “opportunistic infections 
and Ethiopia”, “Pneumocystis Pneumonia and  
Ethiopia”,  “Mycetoma and Ethiopia”,  and “ 
Histoplasmosis and Ethiopia”. Publications starting 
from 1996 and only those publications in English related 
to human fungal infections were included for the 
purpose of this brief communication. 
 
Results 
The existing literature on any fungi in Ethiopia over a 
span of two decades revealed only 91 publications, out 
of which only 45 original articles were on human fungal 
infections. Out of the 45 publications, 17 were on 
superficial infections mainly on dermatophyte 
infections, 14 on mucosal candidiasis and candiduria, 9 
on Cryptococcal meningitis, 4 on Pneumocystis 
pneumonia , and one on fungal keratitis (Table 1).  
According to these reports, superficial infections caused 
by dermatophytes was high ranging from 17% to 73% 
(3,4). After the first case report of Cryptococcal 
infection in a young woman with AIDS in 1992 (5), 
there have been several studies that addressed the 
prevalence of cryptococcal meningitis mainly in patients 
from Addis Ababa (6,7,8). Other invasive infections 
such pneumonia caused by Pneumocystis jirovecii have 
been investigated in some studies, showing its 
importance in the differential diagnosis of smear 
negative HIV positive patients presenting with atypical 
chest x-ray (9,10). Four studies done between 2011 and 
2016 addressed the rising resistance of Candida species 
to commonly used antifungal drugs.  One report shows 
azole resistant Candida isolates from Oropharyngeal 
Candidiasis (OPC) with 11% resistance to fluconazole, 
and another with 32% resistance to one or more 
antifungal agents tested such as fluconazole, 
ketoconazole and itraconazole (11, 12). On the other 
hand, there was no study on invasive fungal infections 
such as blood stream infections with Candida or chronic 
pulmonary Aspergillosis. PubMed search on invasive 
Aspergillosis and Ethiopia returned only one case report 
from 1996 of a bilateral pulmonary aspergilloma 
colonizing an old tuberculous cavity (13). Preliminary 
data in a study on blood stream infection (BSI) among 
febrile cancer patients in Tikur Anbessa Specialized 
Hospital has shown the importance of routine 
surveillance for invasive fungal infections in these 
groups of patients (Personal communication, 
unpublished report). Similarly, there are several 
individual case reports on other unusual systemic 
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Table1: Original articles published on fungal infections in Ethiopia from 1996 to 2016  
Category of fungal infections  Year (Number of articles ) Total  
1996-2002 2003-2009 2010-2016 
Superficial and cutaneous infections 4 2 11 17 
Candidiasis    14 
Cryptococcal meningitis 2 - 7 9 
Fungal keratitis    1 
Pneumocystis pneumonia  - 3 1 4 
Total    45 
 
Discussion 
Fungal infections are common worldwide with over 300 
million people of all ages suffering from serious fungal 
infection every year with rates varying widely from one 
country to another (14). This brief communication is 
based on existing literature and personal observation 
that fungal infections have been neglected and 
understudied in Ethiopia. The available publications 
mostly focus on superficial and cutaneous infections. In 
contrast, there is no data on life threatening invasive 
fungal infections (1) which commonly occur in patients 
with underlying medical conditions and are mostly 
caused by Candida, other yeasts and Aspergillus 
species. 
 
The existing report in the country on the rising resistance 
of yeasts to commonly used antifungal agents (11, 12), 
is a strong indication for more comprehensive research 
on antifungal resistance in the country. Reports on the 
rise of antifungal resistance in Candida and Aspergillus 
species are becoming more common, and one such 
emerging yeast is Candida auris, a multi-drug resistant 
yeast which is increasingly identified in different 
countries worldwide (15). C. auris shares the same risk 
factors as other Candida species although it poses 
challenges not only to treatment but also to 
identification of the species since correct identification 
relies on molecular sequencing (15). Currently almost 
all clinical microbiology laboratories in Ethiopia use 
basic microscopy for fungal identification and do not 
perform fungal culture and identification. 
  
In situations where predisposition to opportunistic 
infections is increasing in Ethiopia, commensurate 
increase in fungal infections is anticipated. Lack or 
limited evidence in Ethiopia on the current state of 
fungal infections particularly of the invasive and life 
threatening infections pose serious challenges to 
service. From personal observation, there is an 
indication that there is low index of suspicion in clinical 
practice, lack of laboratory capacity, and scarcity of 
research focused on these infections. Rapid diagnosis of 
fungi causing invasive infections is important to 
clinically manage patients who are at high risk of 
acquiring these life threatening infections. The clinical 
outcome and high mortality associated with systemic 
fungal infections in patients, especially those who are 
immune-suppressed, should motivate the need to raise 
awareness by renewed effort for improved laboratory 
diagnostic capacity combined with evidence based data 
that will improve knowledge and skill of health care 
professionals. 
 
It is recommended that more research needs to address 
these neglected infections especially focused on 
opportunistic and invasive fungal infections, which will 
contribute to initiation of better and timely approaches 
to appropriate management of patients. 
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